ZNF296
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| zinc finger protein 296 | MIM:613226 | Ensembl:ENSG00000170684 | HGNC:HGNC:15981 | PA37660 | 19q13.32 |
GO terms in ZNF296
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | ND | GO:0005575 | cellular_component |
| CC | IBA | GO:0005634 | nucleus |
| CC | IEA | GO:0005634 | nucleus |
| BP | IBA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IBA | GO:0006355 | regulation of transcription, DNA-templated |
| BP | IBA | GO:0007275 | multicellular organism development |
| BP | ISS | GO:0007283 | spermatogenesis |
| BP | IBA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IBA | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding |
| MF | IEA | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding |
| MF | IBA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
| MF | ND | GO:0003674 | molecular_function |
| MF | IEA | GO:0003676 | nucleic acid binding |
| MF | IBA | GO:0003700 | DNA-binding transcription factor activity |
| MF | IBA | GO:0043565 | sequence-specific DNA binding |
| MF | IBA | GO:0044212 | transcription regulatory region DNA binding |
| MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: ZNF296
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ZNF296
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD241 | Sunitinib | 1 |
| iGMDRD318 | PAC-1 | 1 |
| iGMDRD33 | Entinostat | 2 |
| iGMDRD493 | GSK269962A | 2 |
| iGMDRD96 | S-Trityl-L-cysteine | 1 |
| iGMDRD400 | A-443654 | 2 |
| iGMDRD225 | AC1MD3YP | 1 |
| iGMDRD127 | Seliciclib | 2 |
| iGMDRD332 | A-770041 | 1 |
| iGMDRD658 | CHEMBL1673039 | 2 |
| iGMDRD185 | DMOG | 1 |
| iGMDRD476 | WH-4-023 | 1 |
| iGMDRD239 | Dasatinib | 2 |
| iGMDRD403 | BAY 61-3606 | 1 |
| iGMDRD587 | CHEMBL585951 | 2 |
| iGMDRD409 | Saracatinib | 2 |
| iGMDRD184 | IPA-3 | 1 |
| iGMDRD673 | LSM-1215 | 2 |
| iGMDRD936 | JW-7-52-1 | 1 |
| iGMDRD189 | CGP 60474 | 2 |
| iGMDRD608 | Refametinib | 1 |
| iGMDRD152 | 179324-69-7 | 2 |
| iGMDRD352 | PD-0325901 | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ZNF296

